Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon

被引：2
作者：
Spencer, Hunter C. [1 ,3 ]
Babiarz, Jane [1 ]
Menza, Tim W. [2 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Med, Portland, OR USA
[2] Oregon Hlth Author, HIV STD TB Program, Publ Hlth Div, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Dept Gen Internal Med, 681 SE 8th Ave,Suite 301, Hillsboro, OR 97209 USA
来源：
INTERNATIONAL JOURNAL OF STD & AIDS | 2023年 / 34卷 / 08期
关键词：
HIV prevention; people who inject drugs; pre-exposure prophylaxis; preexposure prophylaxis awareness; HIV-INFECTION; RISK; WILLINGNESS; USERS;
D O I：
10.1177/09564624231154302
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Background Pre-Exposure Prophylaxis (PrEP) to prevent transmission of human immunodeficiency virus (HIV) among people who inject drugs (PWID) has demonstrated efficacy yet awareness of PrEP among PWID is low. Methods 2018 National Behavioral Health Survey data from the Portland, Oregon metropolitan statistical area was analyzed with chi-squared tests and generalized linear models to determine correlates of PrEP awareness among PWID. Results 80% of the sample had at least one indication for PrEP and 15% of the sample was aware of PrEP. Factors associated with higher PrEP awareness were: higher education level (PR = 1.083, CI = 1.018-1.153, p = .012), reporting transactional sex (PR = 1.154, CI = 1.019-1.307, p = .024), and men who have sex with men reporting condomless sex (PR = 1.376, CI = 1.081-1.752, p = .010). Lack of a usual source of care (PR = 0.884, CI = 0.824-0.949, p < .001) was negatively associated with PrEP awareness. Conclusions Interventions to increase PrEP awareness need to target groups with particularly low awareness and be delivered in settings accessible to PWID.
引用
收藏
页码：567 / 573
页数：7
相关论文
共 20 条
[1]  
[Anonymous], 2018, US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States-2017 Update: a clinical practice guideline
[2]  
[Anonymous], 2020, HIV INFECT RISK PREV, V24
[3]   Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs [J].
Biello, K. B. ;
Bazzi, A. R. ;
Mimiaga, M. J. ;
Biancarelli, D. L. ;
Edeza, A. ;
Salhaney, P. ;
Childs, E. ;
Drainoni, M. L. .
HARM REDUCTION JOURNAL, 2018, 15
[4]   Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States [J].
Carter, Gregory ;
Meyerson, Beth ;
Rivers, Patrick ;
Crosby, Richard ;
Lawrence, Carrie ;
Cope, Summer Dawn ;
DeBruicker, David ;
Levin, Steven ;
Meeks, Whitney ;
Thomas, Christopher ;
Turner, Brooklyne ;
Abert, Chris ;
Coles, Haley ;
Allen, Alicia ;
Gonzalez-Fagoaga, Eduardo ;
Grivois-Shah, Ravi .
AIDS AND BEHAVIOR, 2021, 25 (10) :3085-3096
[5]   Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial [J].
Choopanya, Kachit ;
Martin, Michael ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Kitisin, Praphan ;
Natrujirote, Pitinan ;
Kittimunkong, Somyot ;
Chuachoowong, Rutt ;
Gvetadze, Roman J. ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Curlin, Marcel E. ;
Hendrix, Craig W. ;
Vanichseni, Suphak .
LANCET, 2013, 381 (9883) :2083-2090
[6]   Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs [J].
Edelman, E. Jennifer ;
Moore, Brent A. ;
Calabrese, Sarah K. ;
Berkenblit, Gail ;
Cunningham, Chinazo ;
Patel, Viraj ;
Phillips, Karran ;
Tetrault, Jeanette M. ;
Shah, Minesh ;
Fiellin, David A. ;
Blackstock, Oni .
AIDS AND BEHAVIOR, 2017, 21 (04) :1025-1033
[7]   Ending the HIV Epidemic A Plan for the United States [J].
Fauci, Anthony S. ;
Redfield, Robert R. ;
Sigounas, George ;
Weahkee, Michael D. ;
Giroir, Brett P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (09) :844-845
[8]   Behavioral surveillance among people at risk for HIV infection in the US: The National HIV Behavioral Surveillance System [J].
Gallagher, Kathleen M. ;
Sullivan, Patrick S. ;
Lansky, Amy ;
Onorato, Ida M. .
PUBLIC HEALTH REPORTS, 2007, 122 :32-38
[9]   Respondent-driven sampling: A new approach to the study of hidden populations [J].
Heckathorn, DD .
SOCIAL PROBLEMS, 1997, 44 (02) :174-199
[10]   Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs-United States, 2016-2019: Perspectives on Recent Experience and Lessons Learned [J].
Lyss, Sheryl B. ;
Buchacz, Kate ;
McClung, R. Paul ;
Asher, Alice ;
Oster, Alexandra M. .
JOURNAL OF INFECTIOUS DISEASES, 2020, 222 :S239-S249
12